Cardiovascular diseases and cancers are leading causes of morbidity and mortality all over the world. The global burden of these diseases has sharply increased in last two decades and continues to augment due to the growth in aging population and health risk behaviours. Preliminary evidence has suggested the role of inflammation in development and prognosis of cardiovascular diseases as well as cancers. Several studies have explored the relationship between systemic inflammation and cardiovascular mortality. Elevated levels of systemic inflammatory markers have been found associated with incidence of cardiovascular diseases. Furthermore, many epidemiological studies have highlighted that chronic low grade inflammation is associated with diabetes mellitus, hypertension, metabolic syndrome, obesity, smoking, and other lifestyle habits. Systemic inflammation can be measured by using a variety of biochemical and haematological markers. Although novel disease specific biomarkers have been identified, most of which are time consuming and expensive. Observational studies have thoroughly investigated the role of C-reactive protein and total leukocyte count in different chronic conditions. Low grade inflammation measured by White Blood Cell (WBC) count has also been linked to the traditional risk factors of chronic diseases, that is smoking, obesity, hypertension and elevated levels of triglycerides. Recent evidence indicated that the ratio of sub types of blood cells have a significant prognostic value for cardiovascular disease. Elevated levels of neutrophil lymphocyte ratio (NLR) were also found associated with poor survival of patients undergoing coronary artery bypass graft. Many cancer survival studies have suggested that NLR is a significant predictor of overall and disease specific survival of patients. Whether the systemic inflammation, which has proven to be a significant predictor of survival of cancer patients, is malignancy associated inflammation or is because of the any co-morbid conditions that cancer patients may have is still unclear. We assumed that systemic inflammation might also be raised in commonly prevalent conditions. NLR could be an important measure of systemic inflammation as it is cost effective, readily available and could be calculated easily. Little is known and published about NLR and its relationship with prevalent chronic conditions among general population. Therefore, the current study was conducted to investigate the NLR as a measure of systemic inflammation and its relationship, if any, with prevalent chronic diseases.
METHODS: This cross sectional study was conducted in the North of Karachi, the biggest city of Pakistan with a population of 17 million. We invited 1,500 individuals for free medical check up and participation in this study. The study was approved by the independent ethics committee. An information sheet was prepared in English and Urdu to disseminate the objectives of this research study to the participants and written consent was obtained prior to employing a self administered questionnaire. All willing healthy individuals between the ages of 16 to 75 who accepted the invitation to participate were included in this study. Individuals who visited the hospital due to current illness or follow up of a previous illness were excluded. Furthermore, those who had a smoking habit or used any other addictive substances in last 12 months were also excluded. We used a pre-tested self administered questionnaire which included demographic details, lifestyle habits and history of any known chronic disease and current and past use of medications. We also performed a general physical examination of all participants including height, weight and blood pressure measurements. Height and weight were measured removing the shoes, blood pressure was measured three times with a gap of five minutes and the mean value was calculated. A trained nurse was available at the time of examination, and provided support to participants in filling the questionnaire and in some cases where they were unable to fill the questionnaire themselves, she interviewed the participants. We classified subjects as hypertensive if they had a blood pressure of greater than 140/90 mm/Hg or those who had been diagnosed previously. Diabetes mellitus was defined by a fasting blood glucose level of > 126 mg/dl or a self report of previously diagnosed diabetes mellitus. Existence of other chronic conditions (asthma and arthritis) was ascertained by self reporting.
INVESTIGATIONS: We obtained blood samples of all individuals who participated in the study to investigate complete blood count, lipid profile and fasting blood glucose. We used Sysmex Pouch counter (an automated machine) for complete blood count. For complete blood count we took 2 ml of blood in a purple top vaccutainer (containing ethylene diamine tetra acetic acid in it) and after 5 minutes of mixing on rotator, the sample was run in machine and results were obtained.
RESULTS: We invited 1,500 individuals for this study; 1,089 accepted the invitation (response rate 72.6%). Nine individuals were excluded due to current febrile illness, while blood count data were missing for 10 individuals, so the final analysis included 1,070 apparently healthy individuals. We grouped study sample based on NLR tertiles. Generally, individuals in the highest tertile of NLR were slightly older, more likely to be male, taller, heavier and obese. However, there was no statistically significant difference between three groups of NLR. Proportion of individuals with hypertension was higher in middle and highest tertile of NLR as compared to the lowest tertile (18.2% & 16.1% compared to 11.8%). Similar trend was observed with diabetes mellitus, while individuals with asthma and arthritis were more likely to be in the middle tertile of NLR. In a model adjusted for other co-morbid conditions, hypertension and diabetes mellitus were significantly associated with higher NLR, while asthma and arthritis did not show any significant association with NLR. Individuals with hypertension were 43% (RRR = 1.43, 95% CI 0.94-2.20) and 66% (RRR = 1.69, 95% CI 1.09-2.54) more likely to be in the middle and highest tertile of NLR, respectively, compared with baseline group. Similarly, individuals with diabetes mellitus were 53% (RRR = 1.53, 95% CI 0.93-2.51) and 65% (RRR = 1.65, 95% CI 1.01-2.71) more likely to be in the middle and highest tertile of NLR as compared with baseline NLR group. Individuals with asthma and arthritis were 84% and 29% more likely to be in middle tertile of NLR, respectively; however, this association was not statistically significant. We further adjusted for the effects of age, gender and body mass index. In this final multivariate model, NLR has significant association with hypertension and diabetes mellitus. Individuals with asthma and arthritis were more likely to be in the middle group of NLR tertiles, but the association was not significant. Age, gender and body mass index did not have any significant association with NLR in final multivariate model. Furthermore, analysis was also repeated by excluding hypertensive participants (n = 17) who were taking other drugs, including statins and/or aspirin, but overall relationship remains consistent and hypertensive individuals were 56% (RRR = 1.56, 95% CI 1.14-2.45, p-value 0.03) more likely to be in the highest tertile of NLR. Overall relationship between diabetes mellitus and NLR also remained consistent and significantly differed after these exclusions. We also categorised the NLR into quintiles and took the first category as reference, but this did not materially alter the above mentioned associations.
DISCUSSION: In this study, we found a significant association between NLR and likelihood of having hypertension and diabetes mellitus. However, we did not observe a significant relationship between NLR and asthma or arthritis. These relationships remained unchanged even after adjusting for age, gender and obesity. Our study confirms that co-morbid conditions are associated with higher level of systemic inflammation as measured by NLR. However, we could not explore whether the low grade inflammation in the body was a cause of the co-morbid conditions or an effect. Higher level of white blood cells has been previously linked with incident hypertension among different population based studies. Similarly, systemic inflammation has also been reported as a significant factor for metabolic syndrome including obesity and diabetes mellitus. Mechanism underlying these associations between systemic inflammation and prevalent conditions remains to be elucidated. One potential explanation is that cellular response of blood components might be mediated through the endothelial dysfunction. Inflammation modifies endothelial function and an inability of the endothelium to produce nitric oxide and prostacyclin can result in the depletion of vasodilator, antithrombotic and anti-atherogenic properties of the vascular endothelium. In addition, stimulated leukocytes alter rheological properties with an increased capacity to adhere to vascular endothelium and may result in capillary leukocytosis and subsequent increased vascular resistance. Furthermore, several studies have suggested that chronic, low grade, subclinical inflammation play a major role in development of insulin resistance which may then proceed to development of clinically overt diabetes mellitus. Risk factors of diabetes mellitus, such as obesity, smoking and physical inactivity, are associated with chronic, low grade inflammation. So this also explains our findings of a significant relationship between systemic inflammation and diabetes mellitus. We did not find any association of inflammatory markers with asthma and arthritis in this study. This may be explained by intake of anti-inflammatory medications among these individuals. Unlike hypertension and diabetes mellitus, both asthma and arthritis can cause significant pain and discomfort to individuals which lead them towards immediate remedy of the symptoms. In this case, role of inflammation and NLR might have been masked by the intake of anti-inflammatory and pain killer drugs. To our knowledge this is the first study which investigated the role of NLR as measure of systemic inflammation in relation to prevalent chronic conditions in general population. We have a reasonable sample and fair number of cases with each disease to explore any possible relationship between NLR and co-morbid conditions. There are few limitations of this study which are worth to be reported. First, we used a cross sectional design for this study, which is not the best design to investigate any causal relationships; however, this study does raise some questions whether the systemic inflammation is an effect of chronic condition or is it a cause of it. Future research with prospective design and multiple measurements of NLR could provide more robust evidence on role of NLR in relation to co-morbid conditions. Second, it is possible that the relationship between elevated NLR and co-morbid conditions might have confounded by some unmeasured covariates. However, as we selected apparently healthy individuals from the population, this seems unlikely. Finally, some element of bias cannot be excluded, as individuals with high level of systemic inflammation are more likely to visit a doctor and this sample might not be a true representative of the whole population. However, our random invitations might have eliminated some of the effects caused by chance. Despite the limitations of the study, we observed that individuals with prevalent chronic conditions are significantly more likely to have higher level of systemic inflammation and NLR seems a reasonable measure to detect this condition.
CONCLUSIONS: Systemic inflammation measured by NLR has significant association with prevalent chronic conditions. Future research needs to investigate the relationship with longitudinal data to establish the temporal relationship between these.
Extracted from ‘Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population’ authored by Fauzia Imtiaz, Kashif Shafique, Saira Saeed Mirza, Zeenat Ayoob, Priya Vart and Saadiyah Rao
